QA: Dyne Therapeutics Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001818794_2021_Dyne_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001818794')"}

Graph

Absolute values for 0001818794, Dyne Therapeutics Inc.

  xvar xval
0 AssetsCurrent 349,087,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,946,000
3 remainder_Assets 2,301,000
4 LiabilitiesCurrent 10,967,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,447,000
9 ResearchAndDevelopmentExpense 45,200,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -790,000
13 remainder_ComprehensiveNetIncome -27,000
  yvar yval
0 Assets 353,334,000
1 Liabilities 10,967,000
2 Expenses 58,647,000
3 Revenues 0
4 StockholdersEquity 342,367,000
5 NetIncome -59,437,000
6 ComprehensiveNetIncome -59,450,500
7 BaseVar 211,882,500
8 EconomicCapitalRatio 2.91

Edgar->Model Mapping

Feature Distribution

Change over Time